Biosimilars 2018
13th International Conference on Biologics and Biosimilars 2018
Important Dates
About Biosimilars 2018
With so many challenges in research, still class of drug is experiencing the maximum funding with great Returns on Investment (ROI). Keeping these points in mind we are organizing the 13th International Conference on Biologics and Biosimilars during October 24-25, 2018 at Boston, USA with the theme: Emerging Trends in Biosimilars Approvals, Market and Pricing.
Topics
Entrepreneurs investment meet, Biopharmaceuticals, Current challenges in developing biosimilars, Biosimilars analytical strategies, Emerging biosimilars in therapeutics, Regulatory approach for biosimilars, Legal issues and bpci act, Biosimilars research pipeline, Globalization of biosimilars, Drug delivery and development, Clinical development of biosimilars, Intellectual property rights, Current trends in pharmaceutical industry, Bioequivalence assessment, Bcs and ivivc based biowaiversCall for Papers
The major topics for the Conference are as follows:
Current Challenges in Developing Biosimilars, Bio-pharmaceuticals, Biosimilars Analytical Strategies, Emerging Biosimilars in Therapeutics, Regulatory Approach for Biosimilars, Legal Issues and BPCI Act, Biosimilars Research Pipeline, Globalization of Biosimilars, Drug Delivery and Development, Clinical Development Of Biosimilars, Intellectual Property Rights ,Current Trends in Pharmaceutical industry, Bioequivalence Assessment ,BCS and IVIVC Based Biowaivers, Biosimilar Companies and Market Analysis, Challenges in Biosimilars Pharmacovigilance, Brexit Effect on Biosimilars, Entrepreneurs Investment Meet.
Sign up and follow your favorite conferences.
